ResMed Inc. (RMD) earnings
RMD earnings moved a median of +0.26% by the close. Quarterly and annual RMD reports and results, each read against the price at its own news timestamp. Back to the RMD overview →
24 measured RMD earnings events.
Where these RMD earnings landedvs 24 measured RMD earnings reactions
| Middle 50% of RMD earnings reactions | -1.73% to +1.87% |
|---|---|
| Median reaction (to close) | +0.26% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 RMD earnings events with a measured close landed between -1.73% and +1.87%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026 | Press release | -0.08% | -1.25% | |
| Form 10-K RESMED INC For: Jun 30 | SEC filing · Form 10-K | -0.32% | -1.60% | |
| Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026 | Press release | +1.66% | +2.09% | |
| Form 10-Q RESMED INC For: Mar 31 | SEC filing · Form 10-Q | +0.68% | +2.39% | |
| Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026 | Press release | -0.63% | +1.40% | |
| Form 10-Q RESMED INC For: Dec 31 | SEC filing · Form 10-Q | +0.05% | +2.90% | |
| Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026 | Press release | -0.20% | -0.18% | |
| Form 10-Q RESMED INC For: Sep 30 | SEC filing · Form 10-Q | -2.81% | -3.00% | |
| Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025 | Press release | -0.61% | -2.10% | |
| Form 10-K RESMED INC For: Jun 30 | SEC filing · Form 10-K | -0.30% | +1.07% | |
| Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025 | Press release | -0.29% | +0.15% | |
| Form 10-Q RESMED INC For: Mar 31 | SEC filing · Form 10-Q | -0.72% | +1.25% | |
| Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025 | Press release | -1.37% | -2.37% | |
| Form 10-Q RESMED INC For: Dec 31 | SEC filing · Form 10-Q | -6.82% | -9.14% | |
| ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025 | Press release | -0.63% | +0.67% | |
| Form 10-Q RESMED INC For: Sep 30 | SEC filing · Form 10-Q | -1.67% | -1.51% | |
| ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024 | Press release | -0.27% | -2.29% | |
| Form 10-K RESMED INC For: Jun 30 | SEC filing · Form 10-K | -0.04% | +0.36% | |
| ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024 | Press release | -0.27% | +2.23% | |
| Form 10-Q RESMED INC For: Mar 31 | SEC filing · Form 10-Q | -0.41% | +7.16% | |
| ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024 | Press release | +0.87% | +2.02% | |
| Form 10-Q RESMED INC For: Dec 31 | SEC filing · Form 10-Q | -1.72% | -0.88% | |
| ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024 | Press release | +0.58% | +1.82% | |
| Form 10-Q RESMED INC For: Sep 30 | SEC filing · Form 10-Q | -3.85% | -7.02% |
Keep exploring
More RMD: analyst actions → · SEC filings → · RMD overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| TEARLAB CORP (TEAR) | 488 | 0.00% | 43% |
| Odonate Therapeutics, Inc. (ODT) | 487 | 0.00% | 44% |
| Auris Medical Holding AG (EARS) | 484 | -0.75% | 35% |
| Crinetics Pharmaceuticals, Inc. (CRNX) | 482 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.